Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Biomedicines
|
June 6, 2018
Utilizing Peptide Ligand GPCRs to Image and Treat Pancreatic Cancer
Gail L Matters, John F Harms
Clinical & Experimental Metastasis
|
July 15, 2003
MDA-MB-435 human breast carcinoma metastasis to bone
John F Harms, Danny R Welch
Frontiers in Neuroscience
|
September 12, 2019
Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide
John F Harms, Frank S Menniti, Christopher J Schmidt
Clinical & Experimental Metastasis
|
March 26, 2003
KISS1 metastasis suppression and emergent pathways
John F Harms, Danny R Welch, Mary E Miele
Regulatory Peptides
|
May 24, 2008
Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level
Nuray Erin, Güliz Akdas Barkan, John F Harms, et al.
Journal of Immunotoxicology
|
June 24, 2008
The opioid antagonist naltrexone improves murine inflammatory bowel disease
Gail L Matters, John F Harms, Christopher McGovern, et al.
Neuropharmacology
|
December 7, 2007
Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background
Judith A Siuciak, Sheryl A McCarthy, Douglas S Chapin, et al.
International Journal of Oncology
|
December 28, 2010
Role of endogenous cholecystokinin on growth of human pancreatic cancer
Gail L Matters, Christopher McGovern, John F Harms, et al.
The American Journal of Pathology
|
March 25, 2004
Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis
Claire Lugassy, Hynda K Kleinman, Jean A Engbring, et al.
Neuropharmacology
|
June 20, 2006
Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis
Judith A Siuciak, Douglas S Chapin, John F Harms, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Biomedicines
|
June 6, 2018
Utilizing Peptide Ligand GPCRs to Image and Treat Pancreatic Cancer
Gail L Matters, John F Harms
Clinical & Experimental Metastasis
|
July 15, 2003
MDA-MB-435 human breast carcinoma metastasis to bone
John F Harms, Danny R Welch
Frontiers in Neuroscience
|
September 12, 2019
Phosphodiesterase 9A in Brain Regulates cGMP Signaling Independent of Nitric-Oxide
John F Harms, Frank S Menniti, Christopher J Schmidt
Clinical & Experimental Metastasis
|
March 26, 2003
KISS1 metastasis suppression and emergent pathways
John F Harms, Danny R Welch, Mary E Miele
Regulatory Peptides
|
May 24, 2008
Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level
Nuray Erin, Güliz Akdas Barkan, John F Harms, et al.
Journal of Immunotoxicology
|
June 24, 2008
The opioid antagonist naltrexone improves murine inflammatory bowel disease
Gail L Matters, John F Harms, Christopher McGovern, et al.
Neuropharmacology
|
December 7, 2007
Behavioral characterization of mice deficient in the phosphodiesterase-10A (PDE10A) enzyme on a C57/Bl6N congenic background
Judith A Siuciak, Sheryl A McCarthy, Douglas S Chapin, et al.
International Journal of Oncology
|
December 28, 2010
Role of endogenous cholecystokinin on growth of human pancreatic cancer
Gail L Matters, Christopher McGovern, John F Harms, et al.
The American Journal of Pathology
|
March 25, 2004
Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis
Claire Lugassy, Hynda K Kleinman, Jean A Engbring, et al.
Neuropharmacology
|
June 20, 2006
Inhibition of the striatum-enriched phosphodiesterase PDE10A: a novel approach to the treatment of psychosis
Judith A Siuciak, Douglas S Chapin, John F Harms, et al.
Page
of 3